Through its US-based subsidiary AMDL Diagnostics Inc., Radient Pharmaceuticals Corporation (AMEX: RPC) announced today it has extended its partnership with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE